
«Medical Chemistry and Clinical Biochemistry Journal»publishes original research articles on fundamental, clinical-experimental, and applied studies, as well as analytical reviews, lectures, case reports, and supplementary materials covering all current issues in medical chemistry, biochemistry, molecular biology, and laboratory medicine. The primary focus of the publication is on key aspects of studying human disease pathogenesis at the molecular level, the epidemiology of metabolic disorders, specifics of biochemical processes in health and disease, and novel methods for their diagnosis and treatment monitoring.
The scope of interest encompasses a wide range of topics — from the design and synthesis of new biologically active compounds to their pharmacological evaluation, as well as the development of innovative technologies for clinical laboratory practice. Particular attention is given to research aimed at discovering biomarkers and elucidating drug action mechanisms.
The main goal of the journal is to disseminate new knowledge about the chemical foundations of vital bodily functions and pathologies to improve prevention strategies, preclinical and clinical diagnostics, and to enhance the qualifications of medical practitioners and scientific researchers. The publication aims to facilitate the integration of achievements in fundamental science into practical healthcare.
The journal is registered with the Federal Service for Supervision of Communications, Information Technology and Mass Media (ROSKOMNADZOR), registration number PI No. FS77-90549, dated December 16, 2025.
Publication frequency: 4 issues per year.
Distributed by:
In print form — by subscription.
In electronic form — Platinum Open Access.
Editorial office address: Litovskaya St., 2, Saint Petersburg, 194100;
phone/fax: (812) 295-31-55; e‑mail: lt2007@inbox.ru